Approval · Notice of Compliance 3568 · 2003
ZERIT XR: Notice of Compliance 3568
Issued September 5, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3568
- Date
- September 5, 2003
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: extended release capsules; revisions to the product monograph
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZERIT XR | 02247912 | — |
| ZERIT XR | 02247913 | — |
| ZERIT XR | 02247914 | — |
| ZERIT XR | 02247915 | — |